menu
    • menu

    Company profile for Neogene

    NEW Drugs in Dev.: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neogene Therapeutics, Inc. is a pre-clinical stage biotechnology company pioneering development of next-generation, fully personalized engineered T cells therapies for a broad spectrum of cancers. The Company’s engineered T cells target mutated proteins found in cancer cells due to cancer-associated DNA mutations, or neo-antigens, that render tumor cells vulnerable to detection by T cells. Neogene’s proprietary technology ...
    Neogene Therapeutics, Inc. is a pre-clinical stage biotechnology company pioneering development of next-generation, fully personalized engineered T cells therapies for a broad spectrum of cancers. The Company’s engineered T cells target mutated proteins found in cancer cells due to cancer-associated DNA mutations, or neo-antigens, that render tumor cells vulnerable to detection by T cells. Neogene’s proprietary technology platform aims to identify TCR genes with specificity for neo-antigens from tumor biopsies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeogeneUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    689 Fifth Avenue 12th Floor New York, NY 10022
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neogene.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AstraZeneca Abandons Lead TCR Therapy in $200M Neogene Purchase
    AstraZeneca Abandons Lead TCR Therapy in $200M Neogene Purchase

    29 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/astrazeneca-drops-lead-t-cell-receptor-therapy-200m-neogene-buy

    FIERCE BIOTECH
    29 Jul 2025
    Share Share
    AstraZeneca has completed the acquisition of Neogene Therapeutics
    AstraZeneca has completed the acquisition of Neogene Therapeutics

    17 Jan 2023

    // PRESS RELEASE

    https://www.astrazeneca.com/media-centre/press-releases/2023/acquisition-of-neogene-therapeutics-completed.html

    PRESS RELEASE
    17 Jan 2023
    Share Share
    AstraZeneca enters $320m deal to acquire Neogene
    AstraZeneca enters $320m deal to acquire Neogene

    30 Nov 2022

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/astrazeneca-to-acquire-neogene/#:~:text=Following%20the%20acquisition%2C%20Neogene%20will,potential%20for%20fighting%20solid%20tumours.

    PHARMACEUTICAL-TECHNOLOGY
    30 Nov 2022
    Share Share
    Neogen Completes 3M Food Safety Business Merger
    Neogen Completes 3M Food Safety Business Merger

    01 Sep 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/neogen-completes-3m-food-safety-business-merger/?s=79

    BIOSPACE
    01 Sep 2022
    Share Share
    Neogene Nabs Approval of Clinical Trial Application for its First Phase 1 Trial
    Neogene Nabs Approval of Clinical Trial Application for its First Phase 1 Trial

    10 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220510005439/en

    BUSINESSWIRE
    10 May 2022
    Share Share
    Neogene Therapeutics Appoints Han Lee, Ph.D., MBA, as Chief Financial Officer
    Neogene Therapeutics Appoints Han Lee, Ph.D., MBA, as Chief Financial Officer

    14 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210914005419/en

    BUSINESSWIRE
    14 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search